Comparing Dosing Intervals of Nivolumab or Pembrolizumab in Locally Advanced or Metastatic Cancers
Status:
Recruiting
Trial end date:
2025-04-12
Target enrollment:
Participant gender:
Summary
A randomized research study of drugs nivolumab and pembrolizumab in patients with locally
advanced or metastatic cancers. Based on data from earlier studies it appears that the drugs
can be given less often then the currently approved schedule. This trial will compare drug
levels from the blood from standard interval dosing levels versus taking the drugs less
often.